These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36377818)

  • 1. Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma.
    Leith A; Kiiskinen U; Girvan AC; Jen MH; Khela K; Rider A; Massey L; Piercy J
    Future Oncol; 2022 Oct; 18(33):3727-3740. PubMed ID: 36377818
    [No Abstract]   [Full Text] [Related]  

  • 2. Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma.
    Qiao CX; Zhai XF; Ling CQ; Lang QB; Dong HJ; Liu Q; Li MD
    World J Gastroenterol; 2012 Jun; 18(21):2689-94. PubMed ID: 22690079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important and relevant symptoms including pain concerns in hepatocellular carcinoma (HCC): a patient interview study.
    Kaiser K; Mallick R; Butt Z; Mulcahy MF; Benson AB; Cella D
    Support Care Cancer; 2014 Apr; 22(4):919-26. PubMed ID: 24258355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom concerns and quality of life in hepatobiliary cancers.
    Sun V; Ferrell B; Juarez G; Wagman LD; Yen Y; Chung V
    Oncol Nurs Forum; 2008 May; 35(3):E45-52. PubMed ID: 18467279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Impact of Physician and Patient Discordance on Health-Related Quality of Life in US Patients with Acute Myeloid Leukemia.
    Horvath Walsh LE; Rider A; Piercy J; Pike J; Wilson S; Pandya BJ; Medeiros BC
    Oncol Ther; 2019 Jun; 7(1):67-81. PubMed ID: 32700197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-Related Quality of Life in Patients with Hepatocellular Carcinoma Treated with Initial Transarterial Chemoembolization.
    Hinrichs JB; Hasdemir DB; Nordlohne M; Schweitzer N; Wacker F; Vogel A; Kirstein MM; Marquardt S; Rodt T
    Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1559-1566. PubMed ID: 28488104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
    Vogel A; Qin S; Kudo M; Su Y; Hudgens S; Yamashita T; Yoon JH; Fartoux L; Simon K; López C; Sung M; Mody K; Ohtsuka T; Tamai T; Bennett L; Meier G; Breder V
    Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):649-658. PubMed ID: 34087115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
    Ryoo BY; Merle P; Kulkarni AS; Cheng AL; Bouattour M; Lim HY; Breder V; Edeline J; Chao Y; Ogasawara S; Yau T; Garrido M; Chan SL; Daniele B; Norquist JM; Chen E; Siegel AB; Zhu AX; Finn RS; Kudo M
    Cancer; 2021 Mar; 127(6):865-874. PubMed ID: 33231873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-Related Quality of Life as a Prognostic Factor in Patients After Resection of Hepatic Malignancies.
    Tohme S; Sanin GD; Patel V; Bress K; Ahmed N; Krane A; Tsung A; Steel JL
    J Surg Res; 2020 Jan; 245():257-264. PubMed ID: 31421371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
    Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
    Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review of Studies Assessing the Health-Related Quality of Life of Hepatocellular Carcinoma Patients from 2009 to 2018.
    Kang D; Shim S; Cho J; Lim HK
    Korean J Radiol; 2020 Jun; 21(6):633-646. PubMed ID: 32410403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life after Radioembolization for Hepatocellular Carcinoma Using a Digital Patient-Reported Outcome Tool.
    Salem R; Hassan S; Lewandowski RJ; Grace K; Martin RCG; Sichlau MJ; Fung J; Kim E; Chao S; Rosner BI
    J Vasc Interv Radiol; 2020 Feb; 31(2):311-314.e1. PubMed ID: 31732223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician- and patient-reported barriers to hepatocellular carcinoma surveillance: A nationwide survey.
    Teerasarntipan T; Sritunyarat Y; Prathyajuta P; Pitakkitnukun P; Phathong C; Ariyaskul D; Kulkraisri K; Tangkijvanich P; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
    Medicine (Baltimore); 2022 Sep; 101(36):e30538. PubMed ID: 36086710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes in liver transplant recipients with hepatocellular carcinoma.
    Kensinger CD; Feurer ID; O'Dell HW; LaNeve DC; Simmons L; Pinson CW; Moore DE
    Clin Transplant; 2016 Sep; 30(9):1036-45. PubMed ID: 27291713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
    Xing M; Webber G; Prajapati HJ; Chen Z; El-Rayes B; Spivey JR; Pillai AA; Kim HS
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1167-74. PubMed ID: 25675849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom management in hepatocellular carcinoma.
    Sun VC; Sarna L
    Clin J Oncol Nurs; 2008 Oct; 12(5):759-66. PubMed ID: 18842532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar.
    Kim YA; Trinh S; Thura S; Kyi KP; Lee T; Sze S; Richards A; Aronsohn A; Wong GLH; Tanaka Y; Dusheiko G; Nguyen MH
    PLoS One; 2017; 12(8):e0181603. PubMed ID: 28797080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis.
    Palmieri VO; Santovito D; Margari F; Lozupone M; Minerva F; Di Gennaro C; Todarello O; Palasciano G
    Clin Exp Med; 2015 Feb; 15(1):65-72. PubMed ID: 24323278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hepatocellular carcinoma on health related quality of life in Egyptian patients: a single centre study.
    Hamdy H; Fathy Barakat EM; El Folly RF
    J Egypt Soc Parasitol; 2013 Apr; 43(1):183-94. PubMed ID: 23697025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom clusters and quality of life in Korean patients with hepatocellular carcinoma.
    Ryu E; Kim K; Cho MS; Kwon IG; Kim HS; Fu MR
    Cancer Nurs; 2010; 33(1):3-10. PubMed ID: 19926981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.